Given that TFF3 expression is increased in the tumor tissues and sera of patients with CRC, and that the TFF3 receptor CD147 expression is also increased in colon cancer,22 we suggest that elevated TFF3 binds to upregulated CD147 and promotes CRC progression by inducing PTGS2 expression and PGE2 production. Here, PTGS2 is linked to neoplasm.